53267-01-9c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1IPOBOOXFSRWSHL-UHFFFAOYSA-NCibenzoline is a diarylmethane.
53267-01-9DTXSID9022819CHEMBL87045CHEBI:135083Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P280, P301+P317, P302+P352, P321, P330, P332+P317, P362+P364, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Cibenzoline
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
C - Cardiovascular system
QC - Cardiovascular system
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
DescriptionCibenzoline is a structurally novel, class I (quinidine-like) antiarrhythmic agent. It has additional properties of class III and class IV compounds, delaying repolarization and antagonizing the positive inotropic effects of calcium.
UsesCibenzoline acts as a highly active class I antiarrhythmic agent.
UsesCardiac depressant.
DefinitionChEBI: Cibenzoline is a diarylmethane.
No reaction records under the current filter.
Loading…